Lifestyle interventions for diabetic retinopathy during pregnancy: Current evidence from clinical studies.

Q4 Medicine
Tomasz Bartuś, Jerzy Bartuś
{"title":"Lifestyle interventions for diabetic retinopathy during pregnancy: Current evidence from clinical studies.","authors":"Tomasz Bartuś, Jerzy Bartuś","doi":"10.36740/WLek/219973","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Aim: To summarize current evidence on lifestyle interventions, metabolic stabilization and screening strategies relevant to diabetic retinopathy during pregnancy.</p><p><strong>Patients and methods: </strong>Materials and Methods: A narrative review of clinical studies, systematic reviews, meta-analyses and guideline documents was performed using PubMed/MEDLINE, Scopus and Google Scholar. Baseline retinal status in early pregnancy is the strongest predictor of progression. Additional risk is associated with longer diabetes duration, elevated glycated hemoglobin, glycemic variability, nephropathy and hypertensive disorders, including preeclampsia. Women without retinopathy in early pregnancy generally have a low risk of sight-threatening disease during the same gestation, whereas women with pre-existing retinopathy require close surveillance. Lifestyle interventions do not directly treat retinal lesions, but they improve glycemic control, support appropriate gestational weight gain and reduce vascular burden. Evidence also suggests that continuous glucose monitoring and automated insulin delivery may indirectly support retinal protection by improving metabolic stability.</p><p><strong>Conclusion: </strong>Conclusions: In pregnant women with diabetes, ophthalmic screening remains the main clinical priority. However, lifestyle-based metabolic support is a meaningful complementary strategy and should be integrated into antenatal care alongside risk-stratified retinal follow-up.</p>","PeriodicalId":23643,"journal":{"name":"Wiadomosci lekarskie","volume":"79 5","pages":"1076-1080"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiadomosci lekarskie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/WLek/219973","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Aim: To summarize current evidence on lifestyle interventions, metabolic stabilization and screening strategies relevant to diabetic retinopathy during pregnancy.

Patients and methods: Materials and Methods: A narrative review of clinical studies, systematic reviews, meta-analyses and guideline documents was performed using PubMed/MEDLINE, Scopus and Google Scholar. Baseline retinal status in early pregnancy is the strongest predictor of progression. Additional risk is associated with longer diabetes duration, elevated glycated hemoglobin, glycemic variability, nephropathy and hypertensive disorders, including preeclampsia. Women without retinopathy in early pregnancy generally have a low risk of sight-threatening disease during the same gestation, whereas women with pre-existing retinopathy require close surveillance. Lifestyle interventions do not directly treat retinal lesions, but they improve glycemic control, support appropriate gestational weight gain and reduce vascular burden. Evidence also suggests that continuous glucose monitoring and automated insulin delivery may indirectly support retinal protection by improving metabolic stability.

Conclusion: Conclusions: In pregnant women with diabetes, ophthalmic screening remains the main clinical priority. However, lifestyle-based metabolic support is a meaningful complementary strategy and should be integrated into antenatal care alongside risk-stratified retinal follow-up.

妊娠期糖尿病视网膜病变的生活方式干预:来自临床研究的最新证据
目的:总结与妊娠期糖尿病视网膜病变相关的生活方式干预、代谢稳定和筛查策略的现有证据。患者和方法:材料和方法:使用PubMed/MEDLINE、Scopus和谷歌Scholar对临床研究、系统评价、荟萃分析和指南文件进行叙述性综述。妊娠早期视网膜基线状态是妊娠进展的最强预测因子。额外的风险与糖尿病病程延长、糖化血红蛋白升高、血糖变异性、肾病和高血压疾病(包括先兆子痫)有关。妊娠早期无视网膜病变的妇女在同一妊娠期间患视力威胁疾病的风险一般较低,而已有视网膜病变的妇女则需要密切监测。生活方式干预不直接治疗视网膜病变,但他们改善血糖控制,支持适当的妊娠期体重增加和减少血管负担。证据还表明,持续血糖监测和自动胰岛素输送可能通过改善代谢稳定性间接支持视网膜保护。结论:在妊娠糖尿病患者中,眼科筛查仍是主要的临床重点。然而,基于生活方式的代谢支持是一种有意义的补充策略,应与风险分层视网膜随访一起纳入产前保健。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Wiadomosci lekarskie
Wiadomosci lekarskie Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
482
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书